Surveillance Open Access
Like 0


Diagnoses of bacterial sexually transmitted infections (STI) have been increasing in France since their resurgence in the late 1990s. This article presents recent epidemiological trends until 2016 and the patients’ characteristics. STI surveillance relies on sentinel networks: a clinician-based network RésIST (clinical, biological and behavioural data for early syphilis and gonorrhoea), the lymphogranuloma venereum (LGV) network (clinical, biological and behavioural data for rectal LGV, and the laboratory networks Rénachla and Rénago (demographic and biological data for chlamydial infections and gonorrhoea, respectively). Here we describe trends between 2014 and 2016, using data from diagnostic centres which participated regularly during the study period. The number of early syphilis, gonorrhoea and LGV diagnoses increased between 2014 and 2016, particularly in men who have sex with men. An increase in syphilis and gonorrhoea cases was also observed in heterosexuals. Nevertheless, we observed a drop in 2016 for syphilis and chlamydial infections after two decades of increases. Under-reporting and shortage of benzathine penicillin in 2016 may explain this latest evolution. Regular screening of patients and partners, followed by prompt treatment, remains essential to interrupt STI transmission in a context where human immunodeficiency virus (HIV) prevention has expanded towards biomedical prophylaxis.


Article metrics loading...

Loading full text...

Full text loading...



  1. Ndeikoundam N, Viriot D, Fournet N, De Barbeyrac B, Goubard A, Dupin N, et al. Les infections sexuellement transmissibles bactériennes. en France: situation en 2015 et évolutions récentes. [Bacterial sexually transmitted infections in France: recent trends and characteristics in 2015]. Bull Epidemiol Hebd (Paris). 2016; (41-42):738-44. French. Available from: http://invs.santepubliquefrance.fr/beh/2016/41-42/2016_41-42_1.html
  2. La Ruche G, Le Strat Y, Fromage M, Berçot B, Goubard A, de Barbeyrac B, et al. Incidence of gonococcal and chlamydial infections and coverage of two laboratory surveillance networks, France, 2012. Euro Surveill. 2015;20(32):6-15.  https://doi.org/10.2807/1560-7917.ES2015.20.32.21205  PMID: 26290487 
  3. Agence Nationale d'Accréditation et d'Evaluation en Santé. Évaluation du dépistage des infections uro-génitales basses à Chlamydia trachomatis en France. [Evaluation of screening for urogenital chlamydia trachomatis infections in France]. Saint Denis: Agence Nationale d'Accréditation et d'Evaluation en Santé; 2003. French. Available from: https://www.has-sante.fr/portail/upload/docs/application/pdf/Chlamydia_tome2_synth.pdf
  4. Centre National de Référence des infections à chlamydiae. Protocole de surveillance epidémiologique. Surveillance des ano-rectites à Chlamydia trachomatis(CT). [Epidemiological surveillance protocol. Surveillance of ano-rectitis caused by Chlamydia trachomatis]. Bordeaux: Centre National de Référence des infections à chlamydiae; 2010. French. Available from: http://www.cnrchlamydiae.u-bordeaux.fr/wp-content/uploads/2010/04/Protocole-surveillance-des-ano-rectites-%C3%A0-C.-trachomatis-VERSION-WEB.pdf
  5. Haute Autorité de Santé. Évaluation a priori du dépistage de la syphilis en France. [Evaluation of syphilis screening in France]. Saint Denis: Haute Autorité de Santé; 2007. French. Available from: https://www.has-sante.fr/portail/jcms/c_548127/fr/evaluation-a-priori-du-depistage-de-la-syphilis-en-france
  6. Haute Autorité de Santé. Dépistage et prise en charge de l'infection à Neisseria gonorrhoeae: état des lieux et propositions. [Screening and management of Neisseria gonorrhoeae infection: situation analysis and proposal]. Saint Denis: Haute Autorité de Santé; 2010. French. Available from: https://www.has-sante.fr/portail/upload/docs/application/pdf/2011-03/argumentaire_gonocoque_vf.pdf
  7. Haute Autorité de Santé. Réévaluation de la stratégie de dépistage des infections à Chlamydia trachomatis. [Evaluation of the screening strategy for Chlamydia trachomatis infection]. Saint Denis: Haute Autorité de Santé; 2007. French. Available from: https://www.has-sante.fr/portail/upload/docs/application/pdf/2018-10/recommandation_en_sante_publique__reevaluation_de_la_strategie_de_depistage_des_infection_a_chlamydia_trachomatis_vf.pdf
  8. Agence nationale de sécurité du médicament et des produits de santé. Suivi de l’utilisation de Truvada ou génériques pour une prophylaxie préexposition (PrEP) au VIH à partir du SNIIRAM. [Follow-up of the use of Truvada or generic drugs for pre-exposure prophylaxis against HIV based on SNIIRAM]. Saint Denis: Agence nationale de sécurité du médicament et des produits de santé; 2017. French. Available from: https://ansm.sante.fr/var/ansm_site/storage/original/application/8920bfaee846e6ea504e24db469741c2.pdf
  9. European Centre for Disease Prevention and Control (ECDC). Sexually transmitted infections in Europe 2013. Stockholm: ECDC; 2015. Available from: https://ecdc.europa.eu/sites/portal/files/media/en/publications/Publications/sexual-transmitted-infections-europe-surveillance-report-2013.pdf
  10. European Centre for Disease Prevention and Control (ECDC). Chlamydia. In: ECDC. Annual epidemiological report for 2015. Stockholm: ECDC; 2017. Available from: https://ecdc.europa.eu/sites/portal/files/documents/AER_for_2015-chlamydia.pdf
  11. European Centre for Disease Prevention and Control (ECDC). Lymphogranuloma venereum. In: ECDC. Annual epidemiological report for 2015.Stockholm: ECDC; 2017. Available from: https://ecdc.europa.eu/sites/portal/files/documents/AER_for_2015-Lymphogranuloma-venereum.pdf
  12. European Centre for Disease Prevention and Control (ECDC). Syphilis. In: ECDC. Annual epidemiological report for 2015. Stockholm: ECDC; 2017. Available from: https://ecdc.europa.eu/sites/portal/files/documents/AER_for_2015-syphilis.pdf
  13. Public Health England. Sexually transmitted infections and chlamydia screening in England, 2016. Health Protection Report. 2017;11(20). Available from: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/617025/Health_Protection_Report_STIs_NCSP_2017.pdf
  14. Childs T, Simms I, Alexander S, Eastick K, Hughes G, Field N. Rapid increase in lymphogranuloma venereum in men who have sex with men, United Kingdom, 2003 to September 2015. Euro Surveill. 2015;20(48):30076.  https://doi.org/10.2807/1560-7917.ES.2015.20.48.30076  PMID: 26675210 
  15. Public Health England. Sexually transmitted infections and chlamydia screening in England, 2015. Health Protection Report. 2016;10(22):1-27. Available from: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/534601/hpr2216_stis.pdf
  16. Public health England. Recent trends in Lymphogranuloma venereum (LGV) diagnoses in the United Kingdom: 2003-2016. Health Protection Report. 2017;11(37). Available from: https://www.gov.uk/government/publications/lgv-infections-in-the-uk-trends-and-epidemiology
  17. Milhet M, Néfau T, coordinateurs des sites TREND Bordeaux, Lyon, Marseille, Paris et Rennes. CHEMSEX, SLAM Renouvellement des usages de drogues en contextes sexuels parmi les HSH [Renewal of drug use in sexual context among MSM]. Paris: Observatoire français des drogues et des toxicomanies (OFDT); July 2017. French. Available from: https://www.researchgate.net/profile/Thomas_Nefau2/publication/319213531_CHEMSEX_SLAM_Renouvellement_des_usages_de_drogues_en_contextes_sexuels_parmi_les_HSH/links/599c4e27a6fdcc50034c7a3f/CHEMSEX-SLAM-Renouvellement-des-usages-de-drogues-en-contextes-sexuels-parmi-les-HSH.pdf
  18. Velter A, Saboni L, Sommen C, Bernillon P, Bajos N, Semaille C. Sexual and prevention practices in men who have sex with men in the era of combination HIV prevention: results from the Presse Gays et Lesbiennes survey, France, 2011. Euro Surveill. 2015;20(14):21090.  https://doi.org/10.2807/1560-7917.ES2015.20.14.21090  PMID: 25884150 
  19. Stenger MR, Baral S, Stahlman S, Wohlfeiler D, Barton JE, Peterman T. As through a glass, darkly: the future of sexually transmissible infections among gay, bisexual and other men who have sex with men. Sex Health. 2017;14(1):18-27.  https://doi.org/10.1071/SH16104  PMID: 27585033 
  20. Jenness SM, Weiss KM, Goodreau SM, Gift T, Chesson H, Hoover KW, et al. Incidence of gonorrhea and chlamydia following human immunodeficiency virus preexposure prophylaxis among men who have sex with men: a modeling study. Clin Infect Dis. 2017;65(5):712-8.
  21. European Centre for Disease Prevention and Control (ECDC). Guidance on Chlamydia control in Europe 2015. Stockholm: ECDC; 2016. Available from: http://ecdc.europa.eu/en/publications/_layouts/forms/Publication_DispForm.aspx?List=4f55ad51-4aed-4d32-b960-af70113dbb90&ID=1445
  22. La Ruche G, Goubard A, Bercot B, Cambau E, Semaille C, Sednaoui P. Gonococcal infections and emergence of gonococcal decreased susceptibility to cephalosporins in France, 2001 to 2012. Euro Surveill. 2014;19(34):20885. . Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20885 https://doi.org/10.2807/1560-7917.ES2014.19.34.20885  PMID: 25188611 
  23. Poncin T, Fouere S, Braille A, Camelena F, Agsous M, Bebear C, et al. Multidrug-resistant Neisseria gonorrhoeae failing treatment with ceftriaxone and doxycycline in France, November 2017. Euro Surveill. 2018;23(21):1800264.  https://doi.org/10.2807/1560-7917.ES.2018.23.21.1800264  PMID: 29845928 
  24. European Centre for Disease Prevention and Control (ECDC). Gonococcal antimicrobial susceptibility surveillance in Europe, 2015. Stockholm: ECDC; 2017. Available from: https://ecdc.europa.eu/en/publications-data/gonococcal-antimicrobial-susceptibility-surveillance-europe-2015
  25. Mohammed H, Ison CA, Obi C, Chisholm S, Cole M, Quaye N, et al. Frequency and correlates of culture-positive infection with Neisseria gonorrhoeae in England: a review of sentinel surveillance data. Sex Transm Infect. 2015;91(4):287-93.  https://doi.org/10.1136/sextrans-2014-051756  PMID: 25352692 
  26. Unemo M, Shafer WM. Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future. Clin Microbiol Rev. 2014;27(3):587-613.  https://doi.org/10.1128/CMR.00010-14  PMID: 24982323 

Data & Media loading...

Submit comment
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error